Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preparation and Characterization of Self-Microemulsifying Drug Delivery System of Olmesartan Medoxomil for Bioavailability Improvement.

Journal of pharmaceutics·2015
Same author

Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion.

International journal of pharmaceutical investigation·2014
Same author

Preparation and evaluation of sublingual tablets of zolmitriptan.

International journal of pharmaceutical investigation·2014
Same author

Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.

Journal of drug delivery·2013
Same author

Development and validation of the liquid chromatography-tandem mass spectrometry method for quantitative estimation of candesartan from human plasma.

Pharmaceutical methods·2013
Same author

Development and validation of spectrophotometric method for simultaneous estimation of paracetamol and lornoxicam in different dissolution media.

Pharmaceutical methods·2013

Related Experiment Video

Updated: Jul 4, 2026

Density Gradient Multilayered Polymerization (DGMP): A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering
12:54

Density Gradient Multilayered Polymerization (DGMP): A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering

Published on: February 12, 2013

Gastric floating matrix tablets: design and optimization using combination of polymers.

Shailesh T Prajapati1, Laxmanbhai D Patel, Dasharath M Patel

  • 1Department of Pharmaceutics, Shri Sarvajanik Pharmacy College, Mehsana-384001, Gujarat, India. stprajapati@gmail.com

Acta Pharmaceutica (Zagreb, Croatia)
|June 3, 2008
PubMed
Summary

This study optimized a domperidone-loaded gastric floating drug delivery system (GFDDS) using hydroxypropyl methylcellulose, Carbopol, and sodium alginate. The developed model accurately predicts GFDDS performance for enhanced drug delivery.

More Related Videos

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jul 4, 2026

Density Gradient Multilayered Polymerization (DGMP): A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering
12:54

Density Gradient Multilayered Polymerization (DGMP): A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering

Published on: February 12, 2013

Generation of Alginate Microspheres for Biomedical Applications
10:33

Generation of Alginate Microspheres for Biomedical Applications

Published on: August 12, 2012

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems

Background:

  • Gastric floating drug delivery systems (GFDDS) offer prolonged drug release and improved bioavailability.
  • Domperidone is a widely used antiemetic and prokinetic agent with a short half-life, necessitating controlled release formulations.

Purpose of the Study:

  • To develop and optimize a domperidone-loaded GFDDS.
  • To investigate the impact of key polymers on the floating and release characteristics of the GFDDS.

Main Methods:

  • Box-Behnken design was utilized to formulate GFDDS with varying concentrations of hydroxypropyl methylcellulose K4M (HPMC K4M), Carbopol 934P, and sodium alginate.
  • Floating lag time (FLT), total floating time (TFT), drug release kinetics (t50, n), and gel formation were evaluated.
  • Dissolution data was analyzed using the power law model.

Main Results:

  • HPMC K4M significantly influenced floating properties.
  • Carbopol 934P negatively affected floating but controlled drug release.
  • Sodium alginate was crucial for gel formation without impacting floating.
  • A quadratic model was successfully developed to predict GFDDS performance.

Conclusions:

  • The optimized GFDDS formulation demonstrates potential for sustained domperidone release.
  • The developed mathematical model provides a valuable tool for predicting and designing GFDDS with desired characteristics.
  • This study highlights the synergistic role of polymers in achieving effective GFDDS performance.